Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr.

Are medical advancements closing or widening medical disparities? Eugene Manley, Jr., Ph.D., founder and CEO of the STEMM & Cancer Health Equity Foundation, breaks down why equity is still not completely measurable in clinical trials, what proper representation in studies is, and how certain demographics are at a disadvantage for biomarker tests compared to other groups with host Deborah Borfitz. Their conversation explores whether health equity in cancer trials is different compared to commonly occurring diseases and if basket and umbrella trials may help the move the needle. Plus, the latest news on a pioneering phage therapy service, a unique cardiac arrest pilot study, new primary endpoints for cancer trials, and trial disruptions threatening diversity. Listen and let us know in a review: where do you think our time and resources are most needed for equity?  Show Notes  News Roundup  Compassionate use phage therapy  Article in Nature Medicine  Press release from Monash University    Sudden cardiac death research   Study in Prehospital Emergency Care  News on the University of Cincinnati website  New endpoints for cancer trials  Consensus paper in The Lancet Oncology  News on the Medical University of Vienna website  USC and Tempus strategic collaboration  News on the Keck School of Medicine of USC website  Trial disruptions threaten diversity  Article in the Journal of Medical Internet Research  Misinterpreting effects of Alzheimer’s drugs  Research letter in JAMA Neurology  News from Brown University School of Public Health    Guest  Eugene Manley, Jr., Ph.D., founder and CEO of the STEMM & Cancer Health Equity Foundation  The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.